{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:32:30Z","timestamp":1789842750273,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,17]]},"DOI":"10.7759\/cureus.77582","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T13:48:01Z","timestamp":1737121681000},"source":"Crossref","is-referenced-by-count":1,"title":["Cariprazine for Clozapine-Induced Urinary Incontinence in Treatment-Resistant Depression: A Case Report"],"prefix":"10.7759","author":[{"given":"Ana Carolina","family":"Pires","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Marques Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Bajouco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/biom11071030","article-title":"Clozapine: why is it so uniquely effective in the treatment of a range of neuropsychiatric disorders?","volume":"11","author":"Gammon D","year":"2021","unstructured":"Gammon D, Cheng C, Volkovinskaia A, Baker GB, Dursun SM. Clozapine: why is it so uniquely effective in the treatment of a range of neuropsychiatric disorders?. Biomolecules. 2021, 11:1030. 10.3390\/biom11071030","journal-title":"Biomolecules"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1017\/9781009053365.006","article-title":"Targeting dopamine and serotonin receptors for psychosis, mood, and beyond: so-called \u201cantipsychotics\u201d","author":"Stahl","year":"2022","unstructured":"Stahl, SM. Targeting dopamine and serotonin receptors for psychosis, mood, and beyond: so-called \u201cantipsychotics\u201d. Stahl\u2019s Essential Psychopharmacology. Stahl SM (ed): Cambridge University Press, New York, NY; 2022. 159-243. 10.1017\/9781009053365.006"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2478\/gp-2018-0007","article-title":"Nocturnal enuresis is an under-recognised side effect of clozapine: results of a systematic review","volume":"2","author":"Dhillon N","year":"2018","unstructured":"Dhillon N, Heun R. Nocturnal enuresis is an under-recognised side effect of clozapine: results of a systematic review. Glob Psychiatry. 2018, 2:21-30. 10.2478\/gp-2018-0007","journal-title":"Glob Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852922000050","article-title":"Treatment strategies for clozapine-induced nocturnal enuresis and urinary incontinence: a systematic review","author":"Tanzer T","year":"2022","unstructured":"Tanzer T, Warren N, McMahon L, et al.. Treatment strategies for clozapine-induced nocturnal enuresis and urinary incontinence: a systematic review. CNS Spectr. 2022, 1-12. 10.1017\/S1092852922000050","journal-title":"CNS Spectr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2021.10.026","article-title":"Urological adverse drug reactions of psychotropic medication in psychiatric inpatients - a drug surveillance report from German-speaking countries","volume":"144","author":"Winkler D","year":"2021","unstructured":"Winkler D, Grohmann R, Friedrich ME, et al.. Urological adverse drug reactions of psychotropic medication in psychiatric inpatients - a drug surveillance report from German-speaking countries. J Psychiatr Res. 2021, 144:412-20. 10.1016\/j.jpsychires.2021.10.026","journal-title":"J Psychiatr Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2010.25.2.333","article-title":"Use of aripiprazole in clozapine induced enuresis: report of two cases","volume":"25","author":"Lee MJ","year":"2010","unstructured":"Lee MJ, Kim CE. Use of aripiprazole in clozapine induced enuresis: report of two cases. J Korean Med Sci. 2010, 25:333-5. 10.3346\/jkms.2010.25.2.333","journal-title":"J Korean Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1017\/S0790966700001154","article-title":"Treatment considerations in clozapine induced enuresis or incontinence","volume":"27","author":"Apantaku-Olajide TD","year":"2010","unstructured":"Apantaku-Olajide TD. Treatment considerations in clozapine induced enuresis or incontinence. Ir J Psychol Med. 2010, 27:99-100. 10.1017\/S0790966700001154","journal-title":"Ir J Psychol Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(97)81951-6","article-title":"Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"338","author":"Rollema H","year":"1997","unstructured":"Rollema H, Lu Y, Schmidt AW, Zorn SH. Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation. Eur J Pharmacol. 1997, 338:R3-5. 10.1016\/s0014-2999(97)81951-6","journal-title":"Eur J Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5545.196719","article-title":"An exploratory study for bladder dysfunction in atypical antipsychotic-emergent urinary incontinence","volume":"58","author":"Sinha P","year":"2016","unstructured":"Sinha P, Gupta A, Reddi VS, Andrade C. An exploratory study for bladder dysfunction in atypical antipsychotic-emergent urinary incontinence. Indian J Psychiatry. 2016, 58:438-42. 10.4103\/0019-5545.196719","journal-title":"Indian J Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00266.2009","article-title":"Role of 5-HT1A receptors in control of lower urinary tract function in anesthetized rats","volume":"298","author":"Cheng CL","year":"2010","unstructured":"Cheng CL, de Groat WC. Role of 5-HT1A receptors in control of lower urinary tract function in anesthetized rats. Am J Physiol Renal Physiol. 2010, 298:F771-8. 10.1152\/ajprenal.00266.2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-015-0240-2","article-title":"Regulatory effects of 5-hydroxytryptamine receptors on voiding function","volume":"32 Suppl 1","author":"Matsumoto-Miyai K","year":"2015","unstructured":"Matsumoto-Miyai K, Yoshizumi M, Kawatani M. Regulatory effects of 5-hydroxytryptamine receptors on voiding function. Adv Ther. 2015, 32 Suppl 1:3-15. 10.1007\/s12325-015-0240-2","journal-title":"Adv Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000301","article-title":"Urinary retention associated with cariprazine: a case report","volume":"41","author":"Kapulsky L","year":"2018","unstructured":"Kapulsky L, Brody BD. Urinary retention associated with cariprazine: a case report. Clin Neuropharmacol. 2018, 41:230-1. 10.1097\/WNF.0000000000000301","journal-title":"Clin Neuropharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.165176","article-title":"Aripiprazole as a treatment option for clozapine-induced enuresis","volume":"47","author":"Palaniappan P","year":"2015","unstructured":"Palaniappan P. Aripiprazole as a treatment option for clozapine-induced enuresis. Indian J Pharmacol. 2015, 47:574-5. 10.4103\/0253-7613.165176","journal-title":"Indian J Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/0004867415583878","article-title":"Bethanechol and aripiprazole for the management of refractory urinary incontinence in a patient on clozapine","volume":"50","author":"Dadlani N","year":"2016","unstructured":"Dadlani N, Austin M. Bethanechol and aripiprazole for the management of refractory urinary incontinence in a patient on clozapine. Aust N Z J Psychiatry. 2016, 50:182. 10.1177\/0004867415583878","journal-title":"Aust N Z J Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39309","article-title":"Cariprazine for treating schizophrenia, mania, bipolar depression, and unipolar depression: a review of its efficacy","volume":"15","author":"Tarzian M","year":"2023","unstructured":"Tarzian M, Ndrio M, Kaja S, Beason E, Fakoya AO. Cariprazine for treating schizophrenia, mania, bipolar depression, and unipolar depression: a review of its efficacy. Cureus. 2023, 15:e39309. 10.7759\/cureus.39309","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/PTS.0000000000001213","article-title":"Comparison of WHO-UMC and Naranjo scales for causality assessment of reported adverse drug reactions","volume":"20","author":"Pandit S","year":"2024","unstructured":"Pandit S, Soni D, Krishnamurthy B, Belhekar MN. Comparison of WHO-UMC and Naranjo scales for causality assessment of reported adverse drug reactions. J Patient Saf. 2024, 20:236-9. 10.1097\/PTS.0000000000001213","journal-title":"J Patient Saf"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(01)01250-x","article-title":"Dopamine induces intracellular Ca2+ signals mediated by alpha1B-adrenoceptors in rat pineal cells","volume":"430","author":"Rey E","year":"2001","unstructured":"Rey E, Hern\u00e1ndez-D\u00edaz FJ, Abreu P, Alonso R, Tabares L. Dopamine induces intracellular Ca2+ signals mediated by alpha1B-adrenoceptors in rat pineal cells. Eur J Pharmacol. 2001, 430:9-17. 10.1016\/s0014-2999(01)01250-x","journal-title":"Eur J Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.3.12.1773","article-title":"Aripiprazole: profile on efficacy and safety","volume":"3","author":"Goodnick PJ","year":"2002","unstructured":"Goodnick PJ, Jerry JM. Aripiprazole: profile on efficacy and safety. Expert Opin Pharmacother. 2002, 3:1773-81. 10.1517\/14656566.3.12.1773","journal-title":"Expert Opin Pharmacother"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145704005000","article-title":"Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia","volume":"8","author":"Newman-Tancredi A","year":"2005","unstructured":"Newman-Tancredi A, Assi\u00e9 MB, Leduc N, Ormi\u00e8re AM, Danty N, Cosi C. Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia. Int J Neuropsychopharmacol. 2005, 8:341-56. 10.1017\/S1461145704005000","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852916000894","article-title":"Long-term effects of aripiprazole exposure on monoaminergic and glutamatergic receptor subtypes: comparison with cariprazine","volume":"22","author":"Choi YK","year":"2017","unstructured":"Choi YK, Adham N, Kiss B, Gyerty\u00e1n I, Tarazi FI. Long-term effects of aripiprazole exposure on monoaminergic and glutamatergic receptor subtypes: comparison with cariprazine. CNS Spectr. 2017, 22:484-94. 10.1017\/S1092852916000894","journal-title":"CNS Spectr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/324712-cariprazine-for-clozapine-induced-urinary-incontinence-in-treatment-resistant-depression-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T13:48:02Z","timestamp":1737121682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/324712-cariprazine-for-clozapine-induced-urinary-incontinence-in-treatment-resistant-depression-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.77582","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,17]]}}}